1299 related articles for article (PubMed ID: 33507235)
1. Intractable Coronavirus Disease 2019 (COVID-19) and Prolonged Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Replication in a Chimeric Antigen Receptor-Modified T-Cell Therapy Recipient: A Case Study.
Hensley MK; Bain WG; Jacobs J; Nambulli S; Parikh U; Cillo A; Staines B; Heaps A; Sobolewski MD; Rennick LJ; Macatangay BJC; Klamar-Blain C; Kitsios GD; Methé B; Somasundaram A; Bruno TC; Cardello C; Shan F; Workman C; Ray P; Ray A; Lee J; Sethi R; Schwarzmann WE; Ladinsky MS; Bjorkman PJ; Vignali DA; Duprex WP; Agha ME; Mellors JW; McCormick KD; Morris A; Haidar G
Clin Infect Dis; 2021 Aug; 73(3):e815-e821. PubMed ID: 33507235
[TBL] [Abstract][Full Text] [Related]
2. Impact of SARS-CoV-2 in Hematopoietic Stem Cell Transplantation and Chimeric Antigen Receptor T Cell Therapy Recipients.
Mushtaq MU; Shahzad M; Chaudhary SG; Luder M; Ahmed N; Abdelhakim H; Bansal R; Balusu R; DeJarnette S; Divine C; Kribs R; Shune L; Singh AK; Ganguly S; Abhyankar SH; McGuirk JP
Transplant Cell Ther; 2021 Sep; 27(9):796.e1-796.e7. PubMed ID: 34256172
[TBL] [Abstract][Full Text] [Related]
3. SARS-CoV-2 infection in immunocompromised patients: humoral versus cell-mediated immunity.
Wei J; Zhao J; Han M; Meng F; Zhou J
J Immunother Cancer; 2020 Jul; 8(2):. PubMed ID: 32727811
[TBL] [Abstract][Full Text] [Related]
4. Immune Responses to SARS-CoV-2 Vaccination in Young Patients with Anti-CD19 Chimeric Antigen Receptor T Cell-Induced B Cell Aplasia.
Jarisch A; Wiercinska E; Huenecke S; Bremm M; Cappel C; Hauler J; Rettinger E; Soerensen J; Hellstern H; Klusmann JH; Ciesek S; Bonig H; Bader P
Transplant Cell Ther; 2022 Jul; 28(7):366.e1-366.e7. PubMed ID: 35472554
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of Multiple SARS-CoV-2 Vaccine Doses in Patients with B Cell Hematologic Malignancies Receiving Chimeric Antigen Receptor T Cell Therapy: A Contemporary Cohort Analysis.
Abid MB; Rubin M; Szabo A; Longo W; Fenske TS; McCoy C; Lorge A; Abedin S; D'Souza A; Dhakal B; Shah NN; Hamadani M
Transplant Cell Ther; 2024 Mar; 30(3):285-297. PubMed ID: 38142942
[TBL] [Abstract][Full Text] [Related]
6. Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Immunogenicity among Chimeric Antigen Receptor T Cell Therapy Recipients.
Aleissa MM; Little JS; Davey S; Saucier A; Zhou G; Gonzalez-Bocco IH; Crombie JL; Looka A; Baden LR; Issa NC; Hammond SP; Jacobson CA; Sherman AC
Transplant Cell Ther; 2023 Jun; 29(6):398.e1-398.e5. PubMed ID: 36906276
[TBL] [Abstract][Full Text] [Related]
7. State of the CAR-T: Risk of Infections with Chimeric Antigen Receptor T-Cell Therapy and Determinants of SARS-CoV-2 Vaccine Responses.
Meir J; Abid MA; Abid MB
Transplant Cell Ther; 2021 Dec; 27(12):973-987. PubMed ID: 34587552
[TBL] [Abstract][Full Text] [Related]
8. Genomic Diversity of Severe Acute Respiratory Syndrome-Coronavirus 2 in Patients With Coronavirus Disease 2019.
Shen Z; Xiao Y; Kang L; Ma W; Shi L; Zhang L; Zhou Z; Yang J; Zhong J; Yang D; Guo L; Zhang G; Li H; Xu Y; Chen M; Gao Z; Wang J; Ren L; Li M
Clin Infect Dis; 2020 Jul; 71(15):713-720. PubMed ID: 32129843
[TBL] [Abstract][Full Text] [Related]
9. SARS-CoV-2 infections in pediatric and young adult recipients of chimeric antigen receptor T-cell therapy: an international registry report.
McNerney KO; Richards RM; Aguayo-Hiraldo P; Calkoen FG; Talano JA; Moskop A; Balduzzi A; Krajewski J; Dave H; Vatsayan A; Callahan C; Liu H; Li Y; Davis KL; Maude SL
J Immunother Cancer; 2023 Jan; 11(1):. PubMed ID: 36707090
[TBL] [Abstract][Full Text] [Related]
10. Replication of Severe Acute Respiratory Syndrome Coronavirus 2 in Human Respiratory Epithelium.
Milewska A; Kula-Pacurar A; Wadas J; Suder A; Szczepanski A; Dabrowska A; Owczarek K; Marcello A; Ochman M; Stacel T; Rajfur Z; Sanak M; Labaj P; Branicki W; Pyrc K
J Virol; 2020 Jul; 94(15):. PubMed ID: 32434888
[TBL] [Abstract][Full Text] [Related]
11. Identification of Common Deletions in the Spike Protein of Severe Acute Respiratory Syndrome Coronavirus 2.
Liu Z; Zheng H; Lin H; Li M; Yuan R; Peng J; Xiong Q; Sun J; Li B; Wu J; Yi L; Peng X; Zhang H; Zhang W; Hulswit RJG; Loman N; Rambaut A; Ke C; Bowden TA; Pybus OG; Lu J
J Virol; 2020 Aug; 94(17):. PubMed ID: 32571797
[TBL] [Abstract][Full Text] [Related]
12. SARS-CoV-2 T Cell Response in Severe and Fatal COVID-19 in Primary Antibody Deficiency Patients Without Specific Humoral Immunity.
Steiner S; Schwarz T; Corman VM; Gebert L; Kleinschmidt MC; Wald A; Gläser S; Kruse JM; Zickler D; Peric A; Meisel C; Meyer T; Staudacher OL; Wittke K; Kedor C; Bauer S; Besher NA; Kalus U; Pruß A; Drosten C; Volk HD; Scheibenbogen C; Hanitsch LG
Front Immunol; 2022; 13():840126. PubMed ID: 35359967
[TBL] [Abstract][Full Text] [Related]
13. Highly Sensitive Quantification of Plasma Severe Acute Respiratory Syndrome Coronavirus 2 RNA Sheds Light on its Potential Clinical Value.
Veyer D; Kernéis S; Poulet G; Wack M; Robillard N; Taly V; L'Honneur AS; Rozenberg F; Laurent-Puig P; Bélec L; Hadjadj J; Terrier B; Péré H
Clin Infect Dis; 2021 Nov; 73(9):e2890-e2897. PubMed ID: 32803231
[TBL] [Abstract][Full Text] [Related]
14. Genomic Evolution of SARS-CoV-2 Virus in Immunocompromised Patient, Ireland.
Lynch M; Macori G; Fanning S; O'Regan E; Hunt E; O'Callaghan D; McCullagh B; Jennings C; Fortune A
Emerg Infect Dis; 2021 Sep; 27(9):2499-2501. PubMed ID: 34161223
[TBL] [Abstract][Full Text] [Related]
15. Frequently Asked Questions on Coronavirus Disease 2019 Vaccination for Hematopoietic Cell Transplantation and Chimeric Antigen Receptor T-Cell Recipients From the American Society for Transplantation and Cellular Therapy and the American Society of Hematology.
Khawaja F; Papanicolaou G; Dadwal S; Pergam SA; Wingard JR; Boghdadly ZE; Abidi MZ; Waghmare A; Shahid Z; Michaels L; Hill JA; Kamboj M; Boeckh M; Auletta JJ; Chemaly RF
Transplant Cell Ther; 2023 Jan; 29(1):10-18. PubMed ID: 36273782
[TBL] [Abstract][Full Text] [Related]
16. Relationship Between Serum Severe Acute Respiratory Syndrome Coronavirus 2 Nucleic Acid and Organ Damage in Coronavirus 2019 Patients: A Cohort Study.
Xu D; Zhou F; Sun W; Chen L; Lan L; Li H; Xiao F; Li Y; Kolachalama VB; Li Y; Wang X; Xu H
Clin Infect Dis; 2021 Jul; 73(1):68-75. PubMed ID: 32720678
[TBL] [Abstract][Full Text] [Related]
17. High-Throughput, Single-Copy Sequencing Reveals SARS-CoV-2 Spike Variants Coincident with Mounting Humoral Immunity during Acute COVID-19.
Ko SH; Mokhtari EB; Mudvari P; Stein S; Stringham CD; Wagner D; Ramelli S; Ramos-Benitez MJ; Strich JR; Davey RT; Zhou T; Misasi J; Kwong PD; Chertow DS; Sullivan NJ; Boritz EA
bioRxiv; 2021 Feb; ():. PubMed ID: 33655255
[TBL] [Abstract][Full Text] [Related]
18. Host-Virus Chimeric Events in SARS-CoV-2-Infected Cells Are Infrequent and Artifactual.
Yan B; Chakravorty S; Mirabelli C; Wang L; Trujillo-Ochoa JL; Chauss D; Kumar D; Lionakis MS; Olson MR; Wobus CE; Afzali B; Kazemian M
J Virol; 2021 Jul; 95(15):e0029421. PubMed ID: 33980601
[TBL] [Abstract][Full Text] [Related]
19. Successful Chimeric Antigen Receptor (CAR) T-Cell Treatment in Aggressive Lymphoma Despite Coronavirus Disease 2019 (CoVID-19) and Prolonged Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Replication - Case Report.
Nilius-Eliliwi V; Mika T; Baraniskin A; Wünnenberg M; Maslova M; Boy C; Klein-Scory S; Schroers R; Vangala D
Front Oncol; 2021; 11():706431. PubMed ID: 34336692
[TBL] [Abstract][Full Text] [Related]
20. Emergence of Multiple SARS-CoV-2 Antibody Escape Variants in an Immunocompromised Host Undergoing Convalescent Plasma Treatment.
Chen L; Zody MC; Di Germanio C; Martinelli R; Mediavilla JR; Cunningham MH; Composto K; Chow KF; Kordalewska M; Corvelo A; Oschwald DM; Fennessey S; Zetkulic M; Dar S; Kramer Y; Mathema B; Germer S; Stone M; Simmons G; Busch MP; Maniatis T; Perlin DS; Kreiswirth BN
mSphere; 2021 Aug; 6(4):e0048021. PubMed ID: 34431691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
